113 related articles for article (PubMed ID: 6823357)
1. Circulating immune complex levels in patients with molar pregnancy.
Berkowitz RS; Lahey SJ; Rodrick ML; Rayner AA; Goldstein DP; Steele G
Obstet Gynecol; 1983 Feb; 61(2):165-8. PubMed ID: 6823357
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complex levels in patients with gestational trophoblastic neoplasia.
Rayner AA; Berkowitz R; Steele G; Schur PH; Rodrick ML; Goldstein DP; Harte PJ; Wilson RE; Zamcheck N; Munroe AE
J Natl Cancer Inst; 1982 Jul; 69(1):23-6. PubMed ID: 6285061
[TBL] [Abstract][Full Text] [Related]
3. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
[TBL] [Abstract][Full Text] [Related]
4. Measurement of CA-125 in trophoblastic disease.
Kohorn EI
Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
[TBL] [Abstract][Full Text] [Related]
5. Immunobiology of molar pregnancy and gestational trophoblastic tumors.
Berkowitz RS; Goldstein DP; Hoch EJ; Anderson DJ
J Reprod Med; 1984 Nov; 29(11):796-801. PubMed ID: 6097683
[TBL] [Abstract][Full Text] [Related]
6. Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasia.
Lahey SJ; Steele G; Rodrick ML; Berkowitz R; Goldstein DP; Ross DS; Ravikumar TS; Wilson RE; Byrn R; Thomas P
Cancer; 1984 Mar; 53(6):1316-21. PubMed ID: 6198067
[TBL] [Abstract][Full Text] [Related]
7. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
8. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
9. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
[TBL] [Abstract][Full Text] [Related]
10. Decidual immune cell infiltrate in hydatidiform mole.
Hussein MR; Abd-Elwahed AR; Abodeif ES; Abdulwahed SR
Cancer Invest; 2009 Jan; 27(1):60-6. PubMed ID: 19160109
[TBL] [Abstract][Full Text] [Related]
11. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
12. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
13. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
14. Guidelines following hydatidiform mole: a reappraisal.
Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
16. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy.
Schlaerth JB; Morrow CP; Kletzky OA; Nalick RH; D'Ablaing GA
Obstet Gynecol; 1981 Oct; 58(4):478-82. PubMed ID: 7279342
[TBL] [Abstract][Full Text] [Related]
17. Characterization and comparison of two forms of human chorionic gonadotropin from hydatidiform moles with low and high immunoreactivity.
Imamura S; Imamichi S; Yamabe T; Ishiguro M
Am J Obstet Gynecol; 1985 Jan; 151(1):136-41. PubMed ID: 3966497
[TBL] [Abstract][Full Text] [Related]
18. Gestational trophoblastic neoplasia following molar ectopic pregnancy: a case report.
Soares PD; Costa OL; Costa LA; Maestá I
J Reprod Med; 2008 Aug; 53(8):579-82. PubMed ID: 18773621
[TBL] [Abstract][Full Text] [Related]
19. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
[TBL] [Abstract][Full Text] [Related]
20. Development of postmolar trophoblastic disease after partial molar pregnancy.
Goto S; Yamada A; Ishizuka T; Tomoda Y
Gynecol Oncol; 1993 Feb; 48(2):165-70. PubMed ID: 8428686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
